Page last updated: 2024-12-05

oxyclozanide

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

Oxyclozanide is a synthetic anthelmintic drug used primarily to treat parasitic infections in livestock, specifically fasciolosis (liver fluke disease) in ruminants like cattle and sheep. It is a member of the salicylanilide class of compounds, known for their efficacy against various parasitic worms. The compound inhibits the enzyme glutathione S-transferase (GST) in the parasite, which is crucial for detoxification and survival. This inhibition leads to the accumulation of toxic metabolites within the parasite, ultimately resulting in its death. Oxyclozanide's importance lies in its ability to effectively control fasciolosis, a debilitating disease that causes significant economic losses in livestock production. Its effectiveness, ease of administration, and relatively low cost make it a widely used drug in veterinary medicine. Research on oxyclozanide focuses on understanding its mode of action, developing alternative delivery methods, and exploring its potential for treating other parasitic infections.'

Oxyclozanide: Anthelmintic used in grazing animals for fasciola and cestode infestations. [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

FloraRankFlora DefinitionFamilyFamily Definition
FasciolagenusA genus of trematode liver flukes of the family Fasciolidae. Two species of this genus are F. hepatica and F. gigantica. The parasites are found in the liver and gallbladder and associated ducts in mammals and occasionally man. F. gigantica occurs rarely in man.[MeSH]Metzgeriaceae[no description available]

Cross-References

ID SourceID
PubMed CID16779
CHEMBL ID2105450
SCHEMBL ID166224
MeSH IDM0015663

Synonyms (62)

Synonym
oxyclozanide
diplin
2,3,5-trichloro-n-(3,5-dichloro-2-hydroxyphenyl)-6-hydroxybenzamide
c13h6cl5no3
oxiclozanida [inn-spanish]
oxiclozanidum
einecs 218-904-0
oxyclozanide [inn:ban]
oxyclozanidum [inn-latin]
3,3',5,5',6-pentachloro-2,2'-dihydroxybenzanilide
3,5,6,3',5'-pentachloro-2,2'-dihydroxybenzanilide
ccris 5744
brn 2014120
salicylanilide, 3,3',5,5',6-pentachloro-2'-hydroxy-
zanilox
2,2'-dihydroxy-3,3',5,5',6-pentachlorobenzanilide
ici 46638
zanil
benzamide, 2,3,5-trichloro-n-(3,5-dichloro-2-hydroxyphenyl)-6-hydroxy-
3,3',5,5',6-pentachloro-2'-hydroxysalicylanilide
oxyclozanid
benzanilide, 2,2'-dihydroxy-3,3',5,5',6-pentachloro-
D08320
zanil [veterinay] (tn)
2277-92-1
oxyclozanide (inn)
oxyclozanidum
1qs9g4876x ,
oxiclozanida
unii-1qs9g4876x
ici 46683
A816351
ici-46683
CHEMBL2105450
FT-0603601
AKOS015889853
S5017
oxyclozanide [mart.]
oxyclozanide [inn]
oxyclozanide [mi]
oxyclozanide [who-dd]
smr004701204
MLS006010020
SCHEMBL166224
CS-3973
HY-17594
DTXSID50177312
1353867-74-9
sr-01000944913
SR-01000944913-1
oxyclozanide, vetranal(tm), analytical standard
J-014851
mfcd00864507
oxyclosanid-13c6
AS-12188
Q7115903
A16979
CCG-268664
C74174
oxyclozanide 1000 microg/ml in acetonitrile
bdbm430653
SY248027

Research Excerpts

Treatment

ExcerptReferenceRelevance
"Cows treated with oxyclozanide alone at these times produced no more milk than untreated cows."( Responses in milk production to control of gastrointestinal nematode and paramphistome parasites in dairy cattle.
Chang, S; Fraser, GC; Spence, SA, 1996
)
0.62

Toxicity

ExcerptReferenceRelevance
" The recommended dose was safe to use."( Target animal safety testing of an oral salicylanilide suspension, oxyclozanide, for the treatment of fascioliasis in bovine in China.
Bai, Y; Cheng, F; Cheng, H; Dong, Z; Jiang, F; Li, B; Song, E; Sun, J; Wang, W; Wei, X; Zhang, J; Zhou, X; Zhu, Y, 2019
)
0.75

Pharmacokinetics

ExcerptReferenceRelevance
" The aim of the present study was to compare the pharmacokinetic disposition of levamisole (LVM)-oxyclozanide (OXZ) combination in sheep and goats following per os administration."( Comparative pharmacokinetics of levamisole-oxyclozanide combination in sheep and goats following per os administration.
Aksit, D; Gokbulut, C; Veneziano, V; Yalinkilinc, HS, 2014
)
0.88

Dosage Studied

ExcerptRelevanceReference
"The effects of a programme of repeated dosing of all stock for fascioliasis over a four year period on a north Devon farm is described."( Observations on the repeated treatment for fascioliasis of stock on a farm in south-west England.
Whitehead, JD, 1976
)
0.26
" The test cattle were divided into 4 groups, which were treated with 0, 1, 3, and 5 times the recommended dosage through continuous intermittent oral administration at intervals of 2 days."( Target animal safety testing of an oral salicylanilide suspension, oxyclozanide, for the treatment of fascioliasis in bovine in China.
Bai, Y; Cheng, F; Cheng, H; Dong, Z; Jiang, F; Li, B; Song, E; Sun, J; Wang, W; Wei, X; Zhang, J; Zhou, X; Zhu, Y, 2019
)
0.75
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Protein Targets (2)

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Replicase polyprotein 1abSevere acute respiratory syndrome coronavirus 2IC50 (µMol)3.71000.00022.45859.9600AID1804171
Endoplasmic reticulum chaperone BiPHomo sapiens (human)IC50 (µMol)100.00000.80007.02509.1000AID1590351
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (25)

Processvia Protein(s)Taxonomy
ER overload responseEndoplasmic reticulum chaperone BiPHomo sapiens (human)
cerebellum structural organizationEndoplasmic reticulum chaperone BiPHomo sapiens (human)
cerebellar Purkinje cell layer developmentEndoplasmic reticulum chaperone BiPHomo sapiens (human)
substantia nigra developmentEndoplasmic reticulum chaperone BiPHomo sapiens (human)
positive regulation of cell migrationEndoplasmic reticulum chaperone BiPHomo sapiens (human)
negative regulation of transforming growth factor beta receptor signaling pathwayEndoplasmic reticulum chaperone BiPHomo sapiens (human)
endoplasmic reticulum unfolded protein responseEndoplasmic reticulum chaperone BiPHomo sapiens (human)
post-translational protein targeting to membrane, translocationEndoplasmic reticulum chaperone BiPHomo sapiens (human)
negative regulation of protein-containing complex assemblyEndoplasmic reticulum chaperone BiPHomo sapiens (human)
positive regulation of protein ubiquitinationEndoplasmic reticulum chaperone BiPHomo sapiens (human)
protein folding in endoplasmic reticulumEndoplasmic reticulum chaperone BiPHomo sapiens (human)
response to endoplasmic reticulum stressEndoplasmic reticulum chaperone BiPHomo sapiens (human)
maintenance of protein localization in endoplasmic reticulumEndoplasmic reticulum chaperone BiPHomo sapiens (human)
ERAD pathwayEndoplasmic reticulum chaperone BiPHomo sapiens (human)
cellular response to glucose starvationEndoplasmic reticulum chaperone BiPHomo sapiens (human)
negative regulation of apoptotic processEndoplasmic reticulum chaperone BiPHomo sapiens (human)
positive regulation of transcription by RNA polymerase IIEndoplasmic reticulum chaperone BiPHomo sapiens (human)
regulation of protein folding in endoplasmic reticulumEndoplasmic reticulum chaperone BiPHomo sapiens (human)
cellular response to interleukin-4Endoplasmic reticulum chaperone BiPHomo sapiens (human)
regulation of ATF6-mediated unfolded protein responseEndoplasmic reticulum chaperone BiPHomo sapiens (human)
regulation of IRE1-mediated unfolded protein responseEndoplasmic reticulum chaperone BiPHomo sapiens (human)
negative regulation of IRE1-mediated unfolded protein responseEndoplasmic reticulum chaperone BiPHomo sapiens (human)
regulation of PERK-mediated unfolded protein responseEndoplasmic reticulum chaperone BiPHomo sapiens (human)
chaperone cofactor-dependent protein refoldingEndoplasmic reticulum chaperone BiPHomo sapiens (human)
protein refoldingEndoplasmic reticulum chaperone BiPHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (25)

Processvia Protein(s)Taxonomy
3'-5'-RNA exonuclease activityReplicase polyprotein 1abSevere acute respiratory syndrome coronavirus 2
RNA-dependent RNA polymerase activityReplicase polyprotein 1abSevere acute respiratory syndrome coronavirus 2
cysteine-type endopeptidase activityReplicase polyprotein 1abSevere acute respiratory syndrome coronavirus 2
mRNA 5'-cap (guanine-N7-)-methyltransferase activityReplicase polyprotein 1abSevere acute respiratory syndrome coronavirus 2
mRNA (nucleoside-2'-O-)-methyltransferase activityReplicase polyprotein 1abSevere acute respiratory syndrome coronavirus 2
mRNA guanylyltransferase activityReplicase polyprotein 1abSevere acute respiratory syndrome coronavirus 2
RNA endonuclease activity, producing 3'-phosphomonoestersReplicase polyprotein 1abSevere acute respiratory syndrome coronavirus 2
ISG15-specific peptidase activityReplicase polyprotein 1abSevere acute respiratory syndrome coronavirus 2
5'-3' RNA helicase activityReplicase polyprotein 1abSevere acute respiratory syndrome coronavirus 2
protein guanylyltransferase activityReplicase polyprotein 1abSevere acute respiratory syndrome coronavirus 2
calcium ion bindingEndoplasmic reticulum chaperone BiPHomo sapiens (human)
protein bindingEndoplasmic reticulum chaperone BiPHomo sapiens (human)
ATP bindingEndoplasmic reticulum chaperone BiPHomo sapiens (human)
ATP hydrolysis activityEndoplasmic reticulum chaperone BiPHomo sapiens (human)
enzyme bindingEndoplasmic reticulum chaperone BiPHomo sapiens (human)
protein domain specific bindingEndoplasmic reticulum chaperone BiPHomo sapiens (human)
ubiquitin protein ligase bindingEndoplasmic reticulum chaperone BiPHomo sapiens (human)
ribosome bindingEndoplasmic reticulum chaperone BiPHomo sapiens (human)
cadherin bindingEndoplasmic reticulum chaperone BiPHomo sapiens (human)
unfolded protein bindingEndoplasmic reticulum chaperone BiPHomo sapiens (human)
protein-folding chaperone bindingEndoplasmic reticulum chaperone BiPHomo sapiens (human)
misfolded protein bindingEndoplasmic reticulum chaperone BiPHomo sapiens (human)
ATP-dependent protein folding chaperoneEndoplasmic reticulum chaperone BiPHomo sapiens (human)
protein folding chaperoneEndoplasmic reticulum chaperone BiPHomo sapiens (human)
heat shock protein bindingEndoplasmic reticulum chaperone BiPHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (20)

Processvia Protein(s)Taxonomy
double membrane vesicle viral factory outer membraneReplicase polyprotein 1abSevere acute respiratory syndrome coronavirus 2
COP9 signalosomeEndoplasmic reticulum chaperone BiPHomo sapiens (human)
nucleusEndoplasmic reticulum chaperone BiPHomo sapiens (human)
cytoplasmEndoplasmic reticulum chaperone BiPHomo sapiens (human)
mitochondrionEndoplasmic reticulum chaperone BiPHomo sapiens (human)
endoplasmic reticulumEndoplasmic reticulum chaperone BiPHomo sapiens (human)
endoplasmic reticulum lumenEndoplasmic reticulum chaperone BiPHomo sapiens (human)
endoplasmic reticulum membraneEndoplasmic reticulum chaperone BiPHomo sapiens (human)
endoplasmic reticulum-Golgi intermediate compartmentEndoplasmic reticulum chaperone BiPHomo sapiens (human)
cytosolEndoplasmic reticulum chaperone BiPHomo sapiens (human)
plasma membraneEndoplasmic reticulum chaperone BiPHomo sapiens (human)
focal adhesionEndoplasmic reticulum chaperone BiPHomo sapiens (human)
cell surfaceEndoplasmic reticulum chaperone BiPHomo sapiens (human)
membraneEndoplasmic reticulum chaperone BiPHomo sapiens (human)
midbodyEndoplasmic reticulum chaperone BiPHomo sapiens (human)
melanosomeEndoplasmic reticulum chaperone BiPHomo sapiens (human)
intracellular membrane-bounded organelleEndoplasmic reticulum chaperone BiPHomo sapiens (human)
extracellular exosomeEndoplasmic reticulum chaperone BiPHomo sapiens (human)
protein-containing complexEndoplasmic reticulum chaperone BiPHomo sapiens (human)
endoplasmic reticulum chaperone complexEndoplasmic reticulum chaperone BiPHomo sapiens (human)
endoplasmic reticulum lumenEndoplasmic reticulum chaperone BiPHomo sapiens (human)
cytoplasmEndoplasmic reticulum chaperone BiPHomo sapiens (human)
nucleusEndoplasmic reticulum chaperone BiPHomo sapiens (human)
membraneEndoplasmic reticulum chaperone BiPHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (9)

Assay IDTitleYearJournalArticle
AID1854971Antimicrobial activity against Mycobacterium tuberculosis H37Rv incubated for 24 hrs and measured by MTT assay2022Bioorganic & medicinal chemistry, 10-01, Volume: 71Drug screening approach against mycobacterial fatty acyl-AMP ligase FAAL32 renews the interest of the salicylanilide pharmacophore in the fight against tuberculosis.
AID1416227Anthelmintic activity against Paramphistomum assessed as mortality at 40 ug/ml after 4 hrs relative to control2017MedChemComm, Jul-01, Volume: 8, Issue:7
Design, facile synthesis and anthelmintic activity of new
AID1416225Anthelmintic activity against Paramphistomum assessed as mortality at 40 ug/ml after 1 hr relative to control2017MedChemComm, Jul-01, Volume: 8, Issue:7
Design, facile synthesis and anthelmintic activity of new
AID1416226Anthelmintic activity against Paramphistomum assessed as mortality at 40 ug/ml after 2 hrs relative to control2017MedChemComm, Jul-01, Volume: 8, Issue:7
Design, facile synthesis and anthelmintic activity of new
AID1590351Inhibition of GRP78 (26 to 636 residues) (unknown origin) expressed in Escherichia coli BL21 DE3 cells pre-incubated for 10 mins before FITC-NRLLLTG fluorescent peptide addition in presence of 20 uM ADP followed by further incubation for 2 hrs by fluoresc2019Bioorganic & medicinal chemistry letters, 07-15, Volume: 29, Issue:14
A high throughput substrate binding assay reveals hexachlorophene as an inhibitor of the ER-resident HSP70 chaperone GRP78.
AID1416229Anthelmintic activity against Paramphistomum assessed as mortality at 80 ug/ml after 1 hr relative to control2017MedChemComm, Jul-01, Volume: 8, Issue:7
Design, facile synthesis and anthelmintic activity of new
AID741324Induction of internalization of Frizzled1-GFP (unknown origin) expressed in human U2OS cells at 12.5 uM after 6 hrs by confocal microscopy2013Bioorganic & medicinal chemistry letters, Apr-01, Volume: 23, Issue:7
Small molecule modulators of Wnt/β-catenin signaling.
AID1416230Anthelmintic activity against Paramphistomum assessed as mortality at 80 ug/ml after 2 hrs relative to control2017MedChemComm, Jul-01, Volume: 8, Issue:7
Design, facile synthesis and anthelmintic activity of new
AID1804171DRC analysis by immunofluorescence from Article 10.1128/AAC.00819-20: \\Identification of Antiviral Drug Candidates against SARS-CoV-2 from FDA-Approved Drugs.\\2020Antimicrobial agents and chemotherapy, 06-23, Volume: 64, Issue:7
Identification of Antiviral Drug Candidates against SARS-CoV-2 from FDA-Approved Drugs.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (65)

TimeframeStudies, This Drug (%)All Drugs %
pre-199022 (33.85)18.7374
1990's9 (13.85)18.2507
2000's7 (10.77)29.6817
2010's20 (30.77)24.3611
2020's7 (10.77)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 51.62

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be very strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index51.62 (24.57)
Research Supply Index4.23 (2.92)
Research Growth Index4.87 (4.65)
Search Engine Demand Index80.15 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (51.62)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials1 (1.49%)5.53%
Reviews1 (1.49%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other65 (97.01%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]